Prevalence of potential drug-drug interactions in breast cancer patients and determination of their risk factors.

Bibi, Rashida; Azhar, Saira; Iqbal, Ayesha; Jabeen, Hajera; Kalsoom, Umm-E; Iqbal, Muhammad M; Nazeer, Maria

Bibi, Rashida; Azhar, Saira; Iqbal, Ayesha; Jabeen, Hajera; Kalsoom, Umm-E; Iqbal, Muhammad M; Nazeer, Maria.

Afiliación

Bibi R; Department of Pharmacy, COMSATS University Islamabad, Abbottabad, Pakistan.
Azhar S; Department of Pharmacy, University of Sargodha, Sargodha, Pakistan.
Iqbal A; Department of Pharmacy, COMSATS University Islamabad, Abbottabad, Pakistan.
Jabeen H; Department of Breast Cancer, INOR, Abbottabad, Pakistan.
Kalsoom UE; Department of Pharmacy, Quaid-i-Azam University, Islamabad, Pakistan.
Iqbal MM; Department of Medicine, Ayub Teaching Hospital, Abbottabad, Pakistan.
Nazeer M; Department of Pharmacy, COMSATS University Islamabad, Abbottabad, Pakistan.

J Oncol Pharm Pract ; 27(7): 1616-1622, 2021 Oct.

Article en En | MEDLINE | ID: mdl-33086907

Asunto(s)

Neoplasias de la Mama; Preparaciones Farmacéuticas; Neoplasias de la Mama/tratamiento farmacológico; Interacciones Farmacológicas; Femenino; Humanos; Prevalencia; Factores de Riesgo

Palabras clave

Breast cancer; comorbid condition; drug-drug interactions; risk factors

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Preparaciones Farmacéuticas Tipo de estudio: Etiology_studies / Guideline / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: J Oncol Pharm Pract Asunto de la revista: FARMACIA Año: 2021 Tipo del documento: Article País de afiliación: Pakistán

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google